$1 billion for ‘synthetic’ pharma royalties

Fortune | By Dan Primack

Cowen Healthcare Royalty Partners today is expected to announce that it has closed its second fund with a whopping $1 billion in capital commitments.

APPROACH
TEAM
PORTFOLIO

NEWS
CONTACT
INVESTOR LOGIN

HEALTHCARE ROYALTY® and HCRx® are registered trademarks of HealthCare Royalty Management, LLC.

In order to optimize our website for you and to be able to continuously improve it, we use cookies. By continuing to use the website, you agree to the use of cookies. Further information on cookies can be found in our Privacy Policy.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Enable or Disable Cookies